...
机译:Immunoproteomics her2阳性和her2阴性乳腺癌患者积极的淋巴结
Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran.;
Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.;
Tumor Antigens; antigens; Receptor, ErbB-2SerumLymph NodesBreast CancerNP;
机译:Suspicious Cervical Lymph Nodes Detected after Thyroidectomy for Papillary Thyroid Cancer Usually Remain Stable Over Years in Properly Selected Patients
机译:风险分类在淋巴结阴性乳腺癌中的长期预后影响–比较Adjuvant!,St。Gallen和在前瞻性随机Node-Negative-Breast-Cancer-3试验(NNBC-3)中使用的新型风险算法
机译:风险分类在淋巴结阴性乳腺癌中的长期预后影响–比较Adjuvant!,St。Gallen和在前瞻性随机Node-Negative-Breast-Cancer-3试验(NNBC-3)中使用的新型风险算法
机译:在Cancer Patient Portal中发布与癌症相关的故事时的隐私问题
机译:贝伐单抗治疗5例患有乳腺癌和脑转移的患者:Japan Breast Cancer Research Network-07试验
机译:CDO1 promoter methylation is a Biomarker for Outcome prediction of anthracycline Treated, Estrogen Receptor-positive, Lymph Node-positive Breast Cancer patients
机译:Cyclin D1,anchorage-Independent Growth和Breast Cancer。